Hello, and a warm welcome to MedX, where we bring you the latest news and insights from the world of medicine. FDA Approval for Thymidine Kinase 2 Deficiency Treatment The FDA has approved doxecitine and doxribtimine, marking the first approved therapy for thymidine kinase 2 deficiency (TK2d) in adults and pediatric patients with symptom onset at
4525 Reached12 Comments
Woman presented with Fever of Unknown Origin
7731 Reached93 Comments19 Likes
How Physicians Should Manage Stress?
35339 Reached151 Comments202 Likes
Fremanezumab for Prevention and Treatment of Migraine
390 Reached13 Comments11 Likes
Pregnant Woman with HIV-1 Infection
747 Reached1 Likes
Case of Pulmonary Embolism with Syncope
544 Reached4 Likes